Opaleye Management Inc. Impel Pharmaceuticals Inc Transaction History

Opaleye Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$5.78 - $9.32 $639,314 - $1.03 Million	110,608 Added 76.47%	255,250 $1.24 Million
Q2 2022 Aug 15, 2022	BUY	$5.83 - $10.12 $843,262 - $1.46 Million	144,642 New	144,642 $1.35 Million

14.4K

Ticker IMPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,738,800
Market Cap $475K
Description
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.